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Oxidation of skeletal muscle proteins has been reported to occur following contractions, with
ageing, and with a variety of disease states, but the nature of the oxidised proteins has not been
identified. A proteomics approach was utilised to identify major proteins that contain carbonyls
and/or 3-nitrotyrosine (3-NT) groups in the gastrocnemius (GTN) muscles of adult (5–
11 months of age) and old (26–28 months of age) wild type (WT) mice and adult mice lacking
copper, zinc superoxide dismutase (Sod12/2 mice), manganese superoxide dismutase (Sod21/2
mice) or glutathione peroxidase 1 (GPx12/2 mice). In quiescent GTN muscles of adult and old
WT mice, protein carbonylation and/or formation of 3-NT occurred in several proteins involved
in glycolysis, as well as creatine kinase and carbonic anhydrase III. Following contractions, the
3-NT intensity was increased in specific protein bands from GTN muscles of both adult and old
WT mice. In quiescent GTN muscles from adult Sod12/2, Sod21/2 or GPx12/2 mice compared
with age-matched WT mice only carbonic anhydrase III showed a greater 3-NT content. We con-
clude that formation of 3-NT occurs readily in response to oxidative stress in carbonic anhydrase
III and this may provide a sensitive measure of oxidative damage to muscle proteins.
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1 Introduction
Skeletal muscle generates a number of reactive oxygen spe-
cies (ROS) both at rest and during contractile activity (see [1]
for a review) and the primary species generated appear to be
superoxide and nitric oxide (NO) [2–5]. The production of
superoxide and NO results in the formation of secondary
species of ROS, hydroxyl radicals [4, 6] and peroxynitrite [4,
7]. Silveira et al. [8] have also reported the release of sub-
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stantial amounts of hydrogen peroxide from various intra-
cellular sites, including the mitochondria [9]. Increased gen-
eration of ROS in muscles of humans and rodents leads to
oxidative modifications of cellular components [10]. Acute
changes in oxidative modification of proteins, nucleic acids,
carbohydrates and lipids have been reported in skeletal
muscle following periods of contractile activity [11–13].
These acute changes do not result in damage to, or necrosis
of muscle fibres [3], or a loss of contractile function [14], be-
cause the highly specialised antioxidant defense and repair
systems eliminate the ROS-induced oxidative modifications
almost immediately (for reviews see [15, 16]). Chronic
changes in markers of oxidative modification have been
described in skeletal muscle, particularly associated with
ageing [17–19] and with a variety of disease states [20, 21].
ROS react either directly with proteins, or indirectly
through oxidation of sugars or lipids. The oxidised sugars or
lipids then reacting secondarily with protein [22]. The func-
tional consequence of this type of modification of proteins is
unclear and appears to depend upon the protein modified
and the type of modification. Thus, oxidative modifications
may be transient and have little functional effect on the pro-
tein or may produce permanent inactivation of the protein
and loss of protein function with a subsequent accumulation
of damaged proteins [22]. The complexity of the systems
necessitates the identification and function of the specific
proteins that are oxidised under different conditions.
Two oxidative modifications that result from the direct
reaction of ROS with proteins have been studied in detail, the
formation of carbonyl groups (aldehydes and ketones) and
the formation of 3-nitrotyrosine (3-NT) residues. Carbonyl
formation occurs following reaction of proteins with super-
oxide, hydroxyl radical and hydrogen peroxide [23, 24]. The
nitration of tyrosine to form 3-NT residues arises from the
reaction of tyrosine with peroxynitrite (ONOO2) and forma-
tion of 3-NT is generally considered an irreversible oxidative
modification [23]. Following a variety of genetic, physiologi-
cal and pathological perturbations of skeletal muscles, a
generalised increase in protein carbonyl content and
increased formation of 3-NT have been reported [12, 17, 20,
25]. Despite these reports, the specific proteins that undergo
these modifications, or the susceptibility of individual pro-
teins to oxidative modification have not been determined.
For gastrocnemius (GTN) muscles of the mouse, a proteom-
ic approach was used to identify the proteins that contained
carbonyls and/or 3-NT groups. Subsequently, the amount
and the pattern of oxidative modification were examined to
determine which proteins were altered in GTN muscles of
adult and old WT mice at rest, following a contraction proto-
col and in GTN muscles of adult mice deficient in key
enzymes for ROS regulation, copper, zinc superoxide dis-
mutase (CuZnSOD, Sod12/2 mice), manganese superoxide
dismutase (MnSOD, Sod21/2 mice) or glutathione perox-
idase 1 (GPx12/2 mice). We hypothesised that: (i) relatively
few proteins would be oxidised in quiescent GTN muscles of
adult WT mice; (ii) these and additional proteins would
undergo increased oxidative modifications in (a) quiescent
muscles of old WT mice, (b) mice with defective antioxidant
defences, and (c) adult WT mice following a demanding
contraction protocol.
2 Materials and methods
2.1 Chemicals
All chemicals and equipment used during 2-DE were pur-
chased from BioRad (Hemel Hempstead, UK). The antibody
against 3-NT was obtained from Cayman Chemical (Ann
Arbor, MI, USA). Antidinitrophenyl-keyhole limpet hemo-
cyanin conjugate (anti-DNP-KLH) antiserum was obtained
from Molecular Probes (Eugene, OR, USA). 2,4-Dinitro-
phenyl hydrazine (DNPH), secondary antisera conjugated to
HRP and all other reagents (analytical grade) were obtained
from Sigma (Dorset, UK).
2.2 Mice
The studies used male adult (5–11 months) C57Bl/6J, Sod12/2,
Sod21/2, GPx12/2 and C57Bl/6J WT mice and old (26–
28 months) WT mice. Details regarding the generation and
characterisation of the knockout mouse models have been pre-
viously described [26–29]. The Sod12/2 mice were originally
produced in the CD1 strain, and have been backcrossed onto
the C57BL/6J genetic background for at least 12 generations
(B6-Sod1tm1Cje). The Sod21/2 mice were also originally pro-
duced in the CD1 strain, and have been backcrossed onto the
C57BL/6J genetic background for 14 generations (B6-
Sod2tm1Cje). GPx12/2 mice used in this study were originally
generated in the 129Sv/J strain, and were backcrossed for ten
generations onto the C57BL/6J background. Mice were anes-
thetised with pentobarbitone sodium with an initial dose of
65 mg/100 g of body mass via an intraperitoneal injection.
Supplemental doses were administered as required to main-
tain a depth of anaesthesia sufficient to prevent response to
tactile stimuli. Upon completion of an experiment on a given
mouse, the mouse was euthanised by an overdose of the
anaesthetic. Immediately following euthanisation, muscles
were removed quickly and frozen in liquid nitrogen. Muscles
were stored at 2707C until analysis.
2.3 Isometric contraction protocol
Adult (5–11 months) and old (26–30 months) WT mice were
anaesthetised and subjected to an isometric contraction pro-
tocol as previously described [30]. Briefly, the hind limb
musculature were subjected to a 15-min period of electrical
contractions via surface electrodes using a 100 Hz pulse
train at ,70 V for 0.5 s every 4 s with a pulse width of 0.2 ms.
The GTN muscles were then dissected, rapidly frozen in
liquid nitrogen and stored at 2707C until analysis.
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2.4 Detection of proteins with carbonyl groups and
3-NT by 2-DE
Protein extracts were prepared by homogenisation of mus-
cles in 5% v/v b-mercaptoethanol containing Complete™
EDTA-free protease inhibitor cocktail (Roche Diagnostics,
Mannheim, Germany) followed by centrifugation at
10 0006g for 10 min at 47C. Protein content of samples was
determined by using the Lowry assay [31]. Two hundred and
fifty micrograms of total cellular protein extract was recon-
stituted in 185 mL of ReadyPrep rehydration/sample buffer
(8 M urea, 2% CHAPS, 50 mM DTT, 0.2% w/v Bio-Lyte® 3/
10 ampholytes and trace of Bromophenol Blue; BioRad) and
applied to 11 cm, pH 3–10 IPG strips (BioRad). IPG strips
were actively rehydrated at 50 V for 16 h. Following rehydra-
tion, samples on IPG strips were isoelectrically focused
using a Protean IEF cell (BioRad) according to the manu-
facturer’s instructions. All focusing steps were performed at
207C.
For the detection of proteins containing 3-NT, proteins
resolved in the first dimension strips were reduced and al-
kylated prior to second-dimensional electrophoresis. Strips
were incubated for 10 min in equilibration buffer I (6 M
urea, 2% w/v SDS, 0.375 M Tris-HCl (pH 8.8), 20% v/v glyc-
erol and 2% w/v DTT; BioRad) followed by a 10 min incuba-
tion in equilibration buffer II (6 M urea, 2% w/v SDS,
0.375 M Tris-HCl (pH 8.8), 20% v/v glycerol and 2.5% w/v
iodoacetamide; BioRad).
For the detection of proteins containing carbonyl groups,
proteins on the IPG strips were immediately derivatised with
DPNH as previously described [32]. Briefly, following IEF,
strips were placed in 15 mL test tubes and incubated for
20 min in 2 N HCl with 10 mM DNPH at 257C for 20 min.
After the reaction, the samples were washed with 2 M Tris
Base/30% glycerol for 15 min. Sample IPG strips were then
reduced and alkylated as described above.
Duplicate samples of the derivatised/nonderivatised
proteins were separated by SDS-PAGE using a Criterion
system (BioRad). After laying the strip on top of a 10.5–14%
gradient polyacrylamide gel (BioRad) and sealing it with
agarose, electrophoresis was carried out for ,60 min at
200 V. Following electrophoresis, proteins on one gel were
subjected to Western blotting and analysed for protein car-
bonyl or 3-NT content using anti-DNP-KLH or anti-3-NT
antisera, respectively. Proteins on the other gel were stained
overnight with 0.1% w/v CBB R-250 in 40% v/v methanol,
10% v/v acetic acid and were visualised by background
destaining in a solution of 10% v/v acetic acid, 40% v/v
methanol.
Detection of carbonylated proteins was performed by
using Oxyblot™ protein oxidation detection kit (Chemicon
International, Temecula, CA, USA). Briefly, following deri-
vatisation with DNPH, membranes were incubated with
primary and secondary antibodies in PBS containing 0.5%
Tween-20 and 1% w/v BSA. DNP-derivatised proteins were
visualised using a Chemi-Doc System (BioRad) and quanti-
fied using Quantity-one software (BioRad). To determine
band specificity, negative controls (DNPH nonderivatised
samples) were also included in the gels.
Detection of 3-NT on the Western blots was undertaken
by using a mouse mAb (Cat # 189542). Bands were again
visualised using a BioRad Chemi-Doc System (BioRad).
All Western blots produced following 2-DE for the detec-
tion of either protein carbonyls or proteins containing 3-NT,
were subjected to a 60 s exposure in order to minimise
exposure errors and avoid band saturation. In order to corre-
late the protein stain with the Western blot, the gels and blots
were superimposed onto each other according to molecular
weight (MW) and pI range that were extrapolated based on
the dimensions of the gels.
2.5 Characterisation of proteins by MALDI-TOF MS
Excised gel spots were digested with trypsin and spotted
onto a MALDI target plate [33]. MALDI-TOF mass spectra
were acquired on a M@LDI R mass spectrometer (Waters,
Manchester, UK). PMF was carried out using the MASCOT
search engine (www.matrixscience.co.uk). The mono-
isotopic masses of the tryptic peptides were compared to the
NCBI mammalian databases using a mass tolerenace of
150–200 ppm, allowing for one missed tryptic cleavage,
with carbamidomethylation of cysteine residues as a fixed
modification and oxidation of methionine as a variable
modification.
2.6 Quantification of carbonyl groups and 3-NT in
muscle proteins by 1-D electrophoresis and
Western blotting
Protein extracts were prepared by homogenising muscles
in extraction buffer containing 20 mM N-2-hydroxy-
ethylpiperazine-N0-2-ethanesulphonic acid (HEPES),
150 mM NaCl, 1 mM EDTA and 5% v/v b-mercaptoethanol.
Protein content of samples was determined by using the
bicinchoninic acid method (Sigma).
Detection of carbonylated proteins was performed by
using Oxyblot protein oxidation detection kit as described by
the manufacturer (Chemicon International). Briefly, follow-
ing derivatisation with DNPH, 30 mg of muscle protein was
separated on 12% w/v acrylamide gels and transferred to
PVDF membranes by semidry electroblotting.
For quantification of 3-NT in proteins, muscle powder
was placed into a buffer containing 1 mM iodoacetamide,
1 mM benzithonium chloride, 5.7 mM PMSF in 1% w/v
SDS, homogenised on ice and centrifuged at 10 0006g for
10 min at 47C. Protein content of samples was determined by
using the bicinchoninic acid method. Total cellular protein
(50 mg) was separated on 1-D SDS-PAGE followed by West-
ern blotting. The content of 3-NT was again analysed by
using a mouse mAb (Cat # 189542) and the bands were
visualised using a BioRad Chemi-Doc System (BioRad). For
both carbonyl and 3-NT analysis, densitometric quantifica-
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tion of bands was undertaken. Comparisons were only made
between samples on the same gel/Western blot and 3–4
samples in each group were analysed.
2.7 Identification of protein band showing changes in
3-NT immunostaining on 1-D gel
MALDI-TOF MS and PMF were used to identify bands on
the 1-D protein gel that showed changes in 3-NT immuno-
staining following contractile activity or in muscles of the
knockout mice in comparison with WT.
2.8 Statistical analyses
Results are expressed as mean 6 SEM. Multiple compar-
isons were carried our using one-way analysis of variance
with Bonferroni modified t-test where appropriate. Individ-
ual comparisons were carried out using a Student’s t-test. A
p-value of less than 0.05 was considered significant.
3 Results
3.1 Identification of oxidised proteins in skeletal
muscle by 2-DE
A representative CBB-stained gel and a carbonyl blot from
quiescent GTN of adult WT mice are shown in Figs. 1A and
B, respectively. A negative control in which the sample was
not reacted with DNPH showed no positive bands on the blot
(not shown in detail).
PMF resulted in the identification of a number of pro-
teins that contained carbonyl groups in GTN muscle of adult
WT mice. Table 1 summarises those proteins and their loca-
tion on the blot is shown in Fig. 1B.
These data demonstrate that beta-enolase and albumin
are the predominant carbonylated proteins present in GTN
muscle of adult WT mice. In addition, creatine kinase, fruc-
tose-bisphosphate/aldolase A and carbonic anhydrase III
were also identified as containing detectable carbonyl
groups.
3.2 Identification of nitrated proteins by 2-DE
A representative 3-NT blot is shown in Fig. 1C. Negative
control blots in which the primary antibody to 3-NT was
omitted showed no positive bands (data not shown in detail).
PMF-identified carbonic anhydrase III, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), beta-enolase and pyr-
uvate kinase (identified using sequence tags generated by
MS/MS (Q-TOF Micro, Waters) as the major proteins con-
taining detectable 3-NT residues in muscle of WT adult. In
addition, proteins such as creatine kinase and albumin, as
well as aconitase (also identified by tandem MS) also con-
tained detectable levels of 3-NT residues (Table 2). Approxi-
mately half of the total spots submitted to MALDI-TOF-MS
generated good spectra but database searching of the mass
spectra of these proteins did not indicate that they were spe-
cific for a single protein; thus these proteins could not be
unequivocally identified and are not presented in Table 2.
3.3 Effect of contractile activity, ageing or lack of key
antioxidant enzymes on protein carbonyls and
nitrotyrosines
Examination of 2-D carbonyl blots and 3-NT blots obtained
from muscles of the groups of adult WT mice immediately
postcontractile activity compared with resting adult WT, old
WTmice compared with adult WTand adult Sod12/2, Sod21/2
or GPx12/2 mice compared with WT did not reveal any
significant changes in the pattern of oxidised proteins detect-
ed, but it appeared that there were some differences in the
level of the oxidation observed. When carbonyl or 3-NT blots
from 2-D gels were exposed in the visualisation system for the
same length of time, differences in the spot intensity of
different proteins were apparent between the samples from
different experimental groups. Quantitative comparisons of
2-D carbonyl or 3-NT blots between samples from the differ-
ent groups were not possible and quantification was under-
taken using a 1-D approach.
3.4 Detection and quantification of protein carbonyls
in skeletal muscles of mice
In order to quantify the carbonyl content of proteins, muscle
soluble proteins were separated by 1-D SDS-PAGE and the
proteins were analysed for carbonyl content following West-
ern blotting (Figs. 2A and B). Individual bands were quanti-
fied by band densitometry. Muscles from four mice in each
group were analysed and only samples run on the same gel/
Western blot were compared.
The carbonyl blot revealed eight major bands of
MW ,25 (band 1), ,30 (band 2), ,35 (band 3), ,40 (band
4), ,45 (band 5), ,50 (band 6), ,70 (band 7) and ,160
(band 8) kDa (Fig. 2A). None of these bands were detectable
in a negative control (not reacted with DNPH) samples. A
comparison between muscles from adult Sod12/2, Sod21/2
or GPx12/2 mice and muscle from adult WT mice is shown
in Fig. 2A and a comparison between muscles of adult and
old WT mice immediately after the contraction protocol and
adult and old WT mice at rest is shown in Fig. 2B.
The densitometry revealed no major differences in the
carbonyl content of any of the protein bands between quies-
cent muscles from adult male WT, Sod21/2 and GPx12/2
mice. In contrast, quiescent GTN muscles from adult male
Sod12/2 mice demonstrated reduced intensity for bands 2, 3
and 4 (,30, ,35 and ,40 kDa respectively) compared with
those from adult male WT mice. No effect of either age or
contractile activity was seen on the intensity of any of the
carbonyl bands (Fig. 2B).
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Figure 1. 2-DE and immunodetection.
Representative (A) CBB-stained gel, (B)
carbonyl blot and (C) 3-NT blot. The pH
gradient used for IEF and MWs of stand-
ards are indicated for the stained gel. At
least two replicates were performed for
each analysis. The insets to Figs. A and B
show reduced-size images of control
Western blots for the same muscle sam-
ples in which the primary antibody was
omitted.











b-Enolase 160 12 41 6.81 47 206
Fructose bisphosphate aldolase A 133 10 49 8.39 39 656
Carbonic anhydrase III 91 6 39 6.97 29 502
Albumin 128 10 21 5.75 70 700
Creatine kinase 163 13 42 6.58 43 246
© 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.clinical.proteomics-journal.com
Proteomics Clin. Appl. 2007, 1, 362–372 367











b-Enolase 160 12 41 6.81 47 206
Carbonic anhydrase III 91 6 39 6.97 29 502
GAPDH 145 10 45 8.44 36 072
Albumin 128 10 21 5.75 70 700
Fructose bisphosphate aldolase A 133 10 49 8.39 39 656
Creatine kinase 163 13 42 6.58 43 246
Figure 2. Quantification of protein car-
bonyls in quiescent GTN muscle from
(A) adult male WT (u), Sod12/2 (n),
Sod21/2 ( ) and GPx12/2 ( ) mice and
(B) muscles from adult male WT (u) and
old male WT (n) at rest; adult male WT
( ) and old male WT ( ) immediately
postcontractions. A representative lane
shows the bands detected and molecu-
lar weights (MW) are indicated. Data are
presented as mean 6 SEM. *P,0.05
compared with WT male adult quiescent
value at the same point.
3.5 Detection and quantification of 3-NT in protein
from skeletal muscles of mice
In order to quantify the 3-NT content of proteins, muscle-
soluble proteins were separated by 1-D SDS-PAGE and the
proteins were analysed for 3-NT content following Western
blotting (Figs. 3A and B). Individual bands were quantified
by densitometry. Muscles from four mice in each group were
analysed and at least two replicates were performed for each
muscle.
The 3-NT blot revealed four major bands of MW at ap-
proximately 28 (band 1), 60 (band 2), 70 (band 3) and 85
(band 4) kDa (Fig. 2A). A fifth band was also detected
(,50 kDa), but this band appeared to be nonspecific and was
ascribed to an artefact of the secondary antibody used
(mouse IgG heavy chain). Other bands were also present in
the 3-NT blots, but due to their low intensity, quantification
of these bands was not possible. Densitometry revealed a
significant increase in the intensity of band 1 (,28 kDa) in
GTN muscles of Sod12/2, Sod21/2 and GPx12/2 mice com-
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Figure 3. Quantification of 3-NT
in proteins from quiescent GTN
muscle from (A) adult male WT
(u), Sod12/2 (n), Sod21/2 ( )
and GPx12/2 ( ) mice and (B)
muscles from adult male WT (u)
and old male WT (n) at rest;
adult male WT ( ) and old male
WT ( ) immediately post-
contractions. (A) Representative
lanes from the western blot with
the bands detected indicated (i)
and the coomassie-stained gel
(ii) with molecular weights
(MW) indicated. For (B) only the
representative lane from the
western blot is shown. Data are
presented as mean 6 SEM. P
values depicting significant dif-
ferences between groups are
shown in the figure. (C) Peptide
coverage map of carbonic anhy-
drase 3 (EC 4,2,1,1) obtained
from analysis of the protein
band corresponding to band 1
by MALDI-TOF MS and PMF. The
blocks in the peptide coverage
map represent peptides be-
tween the mass range 800–
3500 m/z, peptides smaller than
800 m/z are delineated by ver-
tical ticks on the horizontal line.
Shaded blocks indicate peptides
observed in the MALDI-TOF
mass spectrum. Monoisotopic
[M 1 H]1 peptide masses for
each peptide are labelled.
pared with muscles from quiescent adult male WT mice
(Fig. 3A). No major differences were observed between
quiescent GTN muscles of adult male WT, Sod12/2 and
Sod21/2 mice for bands 2, 3 and 4 (,60, ,70 and ,85 kDa
respectively). In contrast, quiescent muscles from adult male
GPx12/2 mice demonstrated reduced 3-NT content for the
,60, ,70 and ,85 kDa bands compared with those from
adult male WT mice.
The effect of age and contractile activity on 3-NT con-
tent of proteins is shown in Fig. 3B. Densitometry revealed
a significant increase in band 1 (,28 kDa) and a signifi-
cant decrease in band 4 (,85 kDa) in quiescent GTN
muscles of old male WT mice compared with those from
adult male WT mice. Contractile activity resulted in an
increase in the intensity of band 1 and 2 (MW , 28 and
,60 kDa respectively) and a reduction in the intensity of
band 4 (,85 kDa) in GTN muscles of adult male WT mice.
In contrast, in GTN muscles of old male WT mice, con-
tractile activity resulted in an increase in the intensity of
band 4 (,85 kDa).
Since the intensity of 3-NT staining of band 1 (,28 kDa)
showed consistent increases in the different physiological
and pathological models, this protein was identified by
MALDI-TOF MS and PMF as carbonic anhydrase III (EC
4.2.1.1) with a highly significant score of 142 and a sequence
coverage of 71% (Fig. 3C).
4 Discussion
Theoretically, ROS can oxidise all macromolecules, includ-
ing many proteins [34]. Many investigators have identified
the accumulation of oxidised proteins as a key feature of
ageing and of pathological conditions associated with
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increased oxidative stress [22, 35, 36]. Our investigation was
designed to test hypotheses focused on measuring the
number of high-abundance proteins oxidised and the
degree of oxidation of proteins in GTN muscles of old WT
mice, adult mice with severely compromised antioxidant
systems or muscles of adult WT mice after a demanding
contraction protocol, compared with quiescent muscles of
adult WT mice. In addition to testing these hypotheses, our
long-term goal was to identify potential targets which might
provide sensitive markers of oxidative damage to proteins.
Our hypothesis that only a few high abundance proteins in
GTN muscles of adult mice showed oxidation was sup-
ported, but ageing, removal of major antioxidant pathways,
or a challenging contractile protocol had little effect on
either the number of high abundance proteins undergoing
oxidative damage or the level of oxidation of the proteins
identified, although the magnitude of the oxidation was
consistently increased in one protein, carbonic anhydrase
III.
The carbonyl assay has been widely used as a measure
of oxidative damage to proteins, but is relatively nonspecific
[34]. Carbonyl groups were measured by the reaction with
DNPH and in the current assay the product was visualised
by an antibody to dinitrophenylhydrazone. A number of
ROS modify several amino acid residues, particularly histi-
dine, arginine, lysine and proline, to produce end-products
that react with DNPH [34]. Nitration of tyrosine residues
occurs most commonly through a reaction with peroxyni-
trite. Our previous data, obtained after the 15-min contrac-
tion protocol, have indicated that skeletal muscle generates
peroxynitrite, potentially due to the physical proximity of
the plasma membrane superoxide-generating system and
the skeletal muscle nNOS [4, 7]. The relative amounts of
NO and superoxide generated by skeletal muscle cells have
not been carefully examined previously, but most data indi-
cate that relatively greater amounts of NO than superoxide
are formed [4, 7], thus a rise in superoxide generation is
likely to lead to increased peroxynitrite, even in the absence
of any change in NO production. Superoxide appears to be
one of the primary ROS generated by skeletal muscle and
hence one might assume that a substantial increase in
superoxide generation could lead to an increase in carbony-
lation of proteins, an increase in 3-NT formation, or both.
Superoxide activity has been reported to be increased during
contractile activity [37], with ageing [38] and assumed to be
increased in Sod12/2 and Sod21/2 mice [29, 39]. Conse-
quently, changes in the carbonyl content, or 3-NT groups in
specific proteins were expected to provide a sensitive marker
of any rise in superoxide activity.
4.1 Nature of the major proteins containing carbonyl
groups and/or 3-NTs in skeletal muscle
Proteomic analysis identified major proteins with carbonyl
groups and nitrotyrosines in skeletal muscles of mice. Sur-
prisingly, following the contraction protocol, with ageing, or
in mice lacking key antioxidant enzymes, the number of
high-abundance proteins detectable on the carbonyl, or
nitrotyrosine blots did not vary substantially. Despite this
observation, a number of key skeletal muscle proteins were
found that contained either carbonyls, 3-NT, or both. All of
the oxidised proteins identified are the major cytosolic pro-
teins in skeletal muscle. This may reflect the acknowledged
limitations of the current 2-D approach to the separation and
identification of proteins in complex biological tissues [17],
or alternatively these proteins, present in large quantities,
may act as sacrificial sinks for ROS reactions. The presence
of these two modifications in adult WT mice and the lack of
major changes in the physiological and genetic models indi-
cate that these modifications are usually found in mouse
skeletal muscle and are not inevitably associated with any
pathophysiological process. This finding appears consistent
with the increasing recognition of the roles played by ROS in
normal physiology as well as pathophysiological processes
[1].
In each of the different ages, activity and knockout
groups studied, enolase contained both carbonyls and 3-NT.
This key glycolytic enzyme catalyses the conversion of
2-phosphoglycerate into phosphoenolpyruvate. Expression
of beta-enolase is restricted to striated muscles [40]. Enolase
has also been identified as a target of oxidation in different
diseases such as Alzheimer’s [41, 42] and Huntington dis-
ease [43]. A previous study of diaphragm muscles of septic
rats reported high concentrations of oxidised beta-enolase
[21] and a study by Stagsted et al. [44] demonstrated that
enolase is one or the major proteins that is both nitrated and
carbonylated in muscles of chickens.
Oxidation of other key glycolytic enzymes, fructose-
bisphosphate aldolase, GAPDH and pyruvate kinase was
observed in all groups studied. Aldolase A is expressed in
muscle, aldolase B in liver and kidney and aldolase C is
found predominantly in the brain [45]. Carbonylation of
aldolase was reported in diaphragm muscles of septic rats
[21], whereas nitration of aldolase has been reported in the
liver and lungs of septic rats [46] and in skeletal muscles of
adult and old rats [17]. GAPDH, which has been claimed to
be a redox-sensitive enzyme of the glycolytic pathway [47],
contained 3-NT residues. Previous data suggest that this en-
zyme may be irreversibly inactivated by peroxynitrite in rab-
bit skeletal muscle [48]. Pyruvate kinase was also found to
contain 3-NT groups as has previously been reported for rat
skeletal muscle [49].
Creatine kinase (CK), a key enzyme of cellular energy
metabolism, also showed oxidation with the presence of
carbonyl groups and 3-NT residues. It has been claimed that
CK is a prime target for oxidative damage [50, 51] leading to
potential inactivation of CK isoforms. Carbonic anhydrase
III contained both carbonyl and 3-NT residues. Multiple
carbonic anhydrase isoenzymes have been identified, all
varying in developmental expression, subcellular location
and tissue distribution [52], but carbonic anhydrase III is
predominantly found in skeletal muscle. While the exact
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physiological role of carbonic anhydrase III is unknown, a
key role in the cellular response to oxidative stress has been
suggested [53].
Interestingly, an increased 3-NT in aconitase was found
in the present study. Aconitase is an iron–sulphur protein
that catalyses the interconversion between citrate and iso-
citrate during the TCA cycle. Oxidative modification of aco-
nitase can potentially block normal electron flow to oxygen,
leading to accumulation of reduced metabolites such as
NADH and consequently can initiate a cascade with the
potential to cause a dramatic increase in the cellular burden
of oxidative damage [43]. Aconitase appears to be particularly
sensitive to oxidative damage during ageing [54, 55]. Oxi-
dised albumin that appeared to be derived from residual
blood within the muscle tissue was also detected in each of
the samples tested.
4.2 Sensitivity of skeletal muscle proteins to
oxidation
Quantification of the amount of carbonyls and 3-NT in pro-
teins was undertaken using 1-D SDS-PAGE and Western
blotting. This revealed eight major bands (MW ,25, ,30,
,35, ,40, ,45, ,50, ,70 and ,160 kDa) in GTN muscles
for carbonyls and four for 3-NT. Comparisons with the 2-D
gel allowed tentative identification of these proteins. The
contractile activity, age of the mice and the knockout of key
antioxidant enzymes in mice had little effect on the amount
of carbonyls detected on each band, but provided very con-
sistent changes in 3-NT contents.
A protein with a MW of ,28 kDa was nitrated more in
the GTN muscles of Sod12/2, Sod21/2 and GPx12/2 mice
than in quiescent muscles from WT adult male mice. The
same protein was also found to contain more 3-NT in mus-
cles of old WT mice at rest and in adult WT mice following
the contraction protocol. For muscles of WT adult male
mice, the contraction protocol produced an increase in the
3-NT intensity of band with MW ,60 kDa, whereas for
muscles of old WT mice, an increase in 3-NT in a protein
with MW ,85 kDa, likely aconitase, was observed. Analysis
of the protein with MW ,28 kDa on the 1-D gel using
MALDI-TOF MS and PMF confirmed that it was carbonic
anhydrase III (Fig. 3C). Thus, these data indicate that
measurement of 3-NT groups in carbonic anhydrase III may
provide a sensitive and reliable marker of oxidative stress in
skeletal muscle since this was the only change that was
observed in all of the models of increased oxidative stress.
An increase in superoxide generation has been associated
with contractile activity [2, 3, 37], ageing [56] and would be
predicted in the Sod12/2 and Sod21/2 mice [29, 39] and
hence would be expected to increase peroxynitrite genera-
tion. In contrast, the mechanism by which a lack of GPx1,
in GPx12/2 mice might lead to an increase in 3-NT forma-
tion is not immediately clear. The lack of GPx1 would be
predicted to lead to a relative increase in hydrogen peroxide
activity which would not immediately give rise to increased
peroxynitrite, but data from Esposito et al. [57] indicated that
these knockout mice have defective mitochondria with
increased mitochondrial ROS generation. Hence, this may
explain an apparent increase in superoxide in muscle of
these mice. In addition the lack of GPx1 has been reported
to lead to an increase in NO generation that may contribute
to the increased nitration observed [58].
No differential effect on protein carbonyls or 3-NT was
seen between a lack of the SOD predominantly in the mito-
chondria (Sod21/2 mice), or a loss from the cytosol (Sod12/2
mice). This may reflect the fact that mitochondrial proteins
are not present in whole muscle homogenates at a suffi-
ciently high abundance to be detected in the current system,
but also concurs with other data from our laboratory that
demonstrate an increased cytosolic ROS activity in muscle
cells from Sod21/2 mice [59].
A decline in the 3-NT content of some protein bands was
observed for the GTN muscles of GPx12/2 mice (bands 2, 3
and 4), in old WT mice at rest (band 4) and adult WT mice
following the contraction protocol (band 4). The decline may
reflect adaptations in the muscle protein composition that
result from these interventions. Analagous changes may
underlie the decline in carbonyls that occurred in some
bands (2, 3 and 4) of Sod12/2 mice.
Compared with the quiescent GTN muscles of adult and
old male WT mice and of GTN muscles of adult mice fol-
lowing the contraction protocol, no increase was observed in
carbonyl formation in any of the protein bands in muscles of
Sod12/2, Sod21/2 or GPx12/2 mice. This observation was
surprising since the use of less specific methods had indi-
cated an overall increase in the amount of carbonyls detected
in proteins in ageing human brain cells [60], the ageing hu-
man eye [61] as well as in ageing house flies [62]. In skeletal
muscle, Mecocci et al. [63] demonstrated a modest increase
in the overall protein carbonyl content in biopsies from
healthy humans. Previous data from our laboratory have also
shown an age-related accumulation of protein carbonyls [19].
The differences between these studies and our current
results may reflect the specificity of the current assay to sol-
uble individual proteins. Thus, if increases had occurred in
proteins not seen on the gel (i.e. potentially proteins with low
abundance) these may not have been detected with the cur-
rent techniques.
In summary, our data support the conclusion that pro-
tein carbonylation and/or formation of 3-NT in skeletal
muscle affects major proteins involved in glycolysis (aldo-
lase, beta-enolase and GAPDH) as well as regulation of ATP
metabolism (creatine kinase) and hydration of CO2 (carbonic
anhydrase III), but that only formation of 3-NT in carbonic
anhydrase III occurred reproducibly in diverse models of
oxidative stress in skeletal muscles.
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